Sectoral Asset Management »

Corbus Pharmaceuticals Hldgs shares owned by Sectoral Asset Management

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Sectoral Asset Management from 13F filings

Historical chart of Sectoral Asset Management investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Sectoral Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Sectoral Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $188k 20k 9.38

More positions owned by Sectoral Asset Management

Contineum Therapeutics Cl A (CTNM)
Shoulder Innovations Common Stock (SI)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Oruka Therapeutics (ORKA)
Biontech Se Sp Adr (BNTX)
Definium Therapeutics Com Shs (DFTX)
Dex (DXCM)
Arcus Biosciences Incorporated (RCUS)
Amgen (AMGN)
Summit Therapeutics (SMMT)
Irhythm Technologies (IRTC)
Abbvie (ABBV)
Merck & Co (MRK)

View all positions for Sectoral Asset Management

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
OrbiMed Advisors
BlackRock
Standard Life Aberdeen
Diadema Partners
Vanguard Capital Management
Jones Hill Capital
Prosight Management
Caption Management
Susquehanna International
ADAR1 Capital Management
Stonepine Capital Management
Geode Capital Management
Citadel Advisors
Dimensional Fund Advisors

View all funds holding Corbus Pharmaceuticals Hldgs